Abstract: Production of purified, parenterally administrable starch by washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins, subjecting the starch to a molecular weight reduction by acid hydrolysis, and optionally removing residual water-soluble proteins.
Type:
Application
Filed:
June 16, 2003
Publication date:
November 6, 2003
Applicant:
Jagotec AG
Inventors:
Nils Ove Gustavsson, Monica Jonsson, Per Berdeh, Timo Laakso, Mats Reslow
Abstract: Production of purified, parenterally administrable starch by washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins, subjecting the starch to a molecular weight reduction by acid hydrolysis, and optionally removing residual water-soluble proteins.
Purified starch and microparticles based on such starch.
Type:
Grant
Filed:
October 5, 2001
Date of Patent:
September 9, 2003
Assignee:
Jagotec AG
Inventors:
Nils Ove Gustavsson, Monica Jönsson, Per Berdén, Timo Laakso, Mats Reslow
Abstract: A process for producing microparticles containing biologically active substance, in which process an aqueous solution of the said substance is prepared, this solution is mixed with an aqueous solution of PEG such that the substance is concentrated and/or solidified, the substance is optionally washed, the substance is mixed with an organic polymer solution, the composition obtained is mixed, after the admixture of said polymer solution, with an aqueous polymer solution, thereby forming an emulsion of droplets of first mentioned polymer as the internal phase, said droplets are solidified into microparticles, the microparticles are dried and a release-controlling shell is optionally applied to these.
Type:
Grant
Filed:
October 5, 2001
Date of Patent:
September 9, 2003
Assignee:
Jagotec AG
Inventors:
Monica Jönsson, Timo Laakso, Mats Reslow
Abstract: A pharmaceutical composition utilized for increasing neovascularization and angiogenesis during wound healing in a mammal beyond the level of neovascularization and angiogenesis which would occur at the wound site without any treatment, said composition comprising an effective amount of any angiostatic steroid which has reduced or no deteriorative or detrimental side effects combined with an effective amount of a form of hyaluronan such as hyaluronic acid and pharmaceutically acceptable salts thereof.
Type:
Grant
Filed:
July 11, 1997
Date of Patent:
July 22, 2003
Assignee:
Jagotec AG
Inventors:
Michael P. Seed, Chandan Alam, Derek A. Willoughby
Abstract: This invention relates to the oral administration of forms of hyaluronic acid (for example hyaluronan (hyaluronic acid) and pharmaceutically acceptable salts thereof such as sodium hyaluronate), and orally administrable dosage forms containing forms of hyalruonic acid, for the prevention and/or treatment of diseases and/or conditions such as the prevention of restenosis and the treatment of an infarct (heart attack) or a stroke. The oral administration and the orally administered dosage forms may also include therapeutic agents and/or medicines which may be administered orally for the treatment and/or prevention of the diseases and/or conditions with the forms of hyaluronic acid (hyaluronan) previously described.
Abstract: Pharmaceutical tablet, capable of delivering the active substance or the active substances, according to a predeterminable release profile, comprising a core with an external partial coating in which said core consists of 3 layers, wherein the upper layer contains an amount of the active substance with suitable excipients, the intermediate layer consists of polymeric material with retarding barrier function and the lower layer contains the remaining amount of the active substance with suitable excipients and said external coating consists of controlled permeability polymeric materials, applied by compression to the lower surface and to the lateral surface of the core.
Abstract: It is described a new method for the preparation of pharmaceutical tablets carrying poorly soluble in water principle; this method allows to obtain tablets with fast and/or slow release of the active principle. The peculiar feature is the fact that the poorly soluble in water active principle (es: nifedipine) is treated with a surfactant, during the granulation phase or whatever during the preparation process; the obtained product, subjected to a compression, produces pharmaceutical tablets which show high bioavailability of the carried active principle. This procedure can be used to prepare polymeric matrixes (with modified release), formed by tablets with one or more layers. The procedure of manufacture and the characteristics of the new finished tablet are described.
Type:
Grant
Filed:
September 1, 1998
Date of Patent:
April 24, 2001
Assignee:
Jagotec AG
Inventors:
Lauretta Maggi, Ubaldo Conte, Pascal Grenier, Guy Vergnault, Robert Zimmer
Abstract: Pharmaceutical tablet consisting of a first layer containing one or more drugs with immediate or controlled release formulation, a second layer containing one or more drugs, either equal to or different from the first layer, with slow release formulation, and a low-permeability barrier-type layer coating said second layer or, alternatively, placed between the first and second layer and, if necessary, containing a drug.
Abstract: Described herein is a particular type of pharmaceutical tablet, for oral use, which is formed by one or more layers, and is specifically designed for controlled release of active principles that present problems of bio-availability linked to absorption in the gastro-intestinal tract, and in particular active principles that present an erratic and unpredictable absorption linked to the presence or absence of food at the level of the stomach and/or of the first portion of the small intestine, the said pharmaceutical form being characterized in that it is completely coated with one or more films of a biocompatible and biodegradable polymeric material.
Type:
Grant
Filed:
January 6, 1998
Date of Patent:
February 22, 2000
Assignee:
Jagotec AG
Inventors:
Ubaldo Conte, Lauretta Maggi, Pascal Grenier, Guy Vergnault, Robert Zimmer
Abstract: A process is described for preparing pharmaceutical compositions by co-grinding or dry mixing the active substance with cyclodextrins or with hydrophilic polymer materials which swell on contact with water. Homogeneous compositions are obtained from which the active substance is released very rapidly into an aqueous medium.
Type:
Grant
Filed:
September 7, 1995
Date of Patent:
December 15, 1998
Assignee:
Jagotec AG
Inventors:
Ubaldo Conte, Aldo La Manna, Paolo Giunchedi
Abstract: A description is given of a pharmaceutical form for oral administration consisting of a two- or three-layers tablet, wherein at least one layer can rapidly swell by contact with biological and/or aqueous fluids, said swelling resulting in a considerable increase in the tablet volume. Said phenomenon determines a prolonged residence of the pharmaceutical form at the gastric level and therefore allows a slow release of the active ingredient from said pharmaceutical form to the stomach and/or the first tract of the intestine.
Abstract: Pharmaceutical tablet consisting of a first layer containing one or more drugs with immediate or controlled release formulation, a second layer containing one or more drugs, either equal to or different from the first layer, with slow release formulation, and a low-permeability barrier-type layer coating said second layer or, alternatively, placed between the first and second layer and, if necessary, containing a drug.
Type:
Grant
Filed:
March 24, 1995
Date of Patent:
April 14, 1998
Assignee:
Jagotec AG
Inventors:
Ubaldo Conte, Aldo La Manna, Lauretta Maggi
Abstract: A pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times produced via the steps of: a) preparing a tablet consisting of three superposed layers, the upper layer containing an active ingredient, the intermediate layer not containing any active ingredient and forming a barrier-type layer, and the lower layer containing an active ingredient, said upper layer presenting a raised top, b) coating the tablet entirely with an impermeable polymeric film, and c) removing said raised top and thus allowing contact of the abraded upper layer surface with the environment.
Type:
Grant
Filed:
October 24, 1995
Date of Patent:
July 22, 1997
Assignee:
Jagotec AG
Inventors:
Ubaldo Conte, Aldo La Manna, Lauretta Maggi
Abstract: A process is described for preparing pharmaceutical compositions by co-grinding or dry mixing the active substance with cyclodextrins or with hydrophilic polymer materials which swell on contact with water. Homogeneous compositions are obtained from which the active substance is released very rapidly into an aqueous medium.
Type:
Grant
Filed:
October 11, 1994
Date of Patent:
December 19, 1995
Assignee:
Jagotec AG
Inventors:
Ubaldo Conte, Aldo La Manna, Paolo Giunchedi
Abstract: Pharmaceutical tablets releasing the active substance after a definite period of time, consisting of: a core containing the active substance and polymeric substances which swell and/or gel and/or erode on contact with water or with aqueous liquids; a layer applied externally to said core, suitable to prevent the immediate release of the active substance contained in the core and to allow the release of said active substance after a definite period of time, consisting of natural and/or synthetic polymeric materials of the class of the hydrophilic polymers which erode and/or gel and/or dissolve in an aqueous medium; a possible gastroresistant and enterosoluble coating.
Type:
Grant
Filed:
May 24, 1994
Date of Patent:
November 7, 1995
Assignee:
Jagotec AG
Inventors:
Ubaldo Conte, Aldo La Manna, Lauretta Maggi
Abstract: Tablets with zero order controlled-rate of release of the active substances, consisting of a core of defined geometrical form containing the active substance, polymer substances which swell on contact with aqueous liquids and polymer substances with gelling properties, and a support applied to said core to partly cover its surface, the support consisting of polymer substances which are slowly soluble and/or slowly gellable in aqueous liquids, plasticizing substances, and possibly substances with an adjuvant function.
Type:
Grant
Filed:
September 21, 1993
Date of Patent:
June 6, 1995
Assignee:
Jagotec AG
Inventors:
Ubaldo Conte, Aldo La Manna, Paolo Colombo
Abstract: A system for the controlled-rate release of active substances, consisting of:(a) a deposit-core comprising the active substance and having defined geometric form;(b) a support-platform applied to said deposit-core.Said deposit-core contains, mixed with the active substance, a polymeric material having a high degree of swelling on contact with water or aqueous liqids, a gellable polymeric material, said polymeric materials being replaceable by a single polymeric material having both swelling and gelling properties, and other adjuvants able to provide the mixture with suitable characteristics for its compression and for its intake of water.
Type:
Grant
Filed:
December 9, 1986
Date of Patent:
June 13, 1989
Assignee:
Jagotec AG
Inventors:
Paolo Colombo, Aldo La Manna, Ubaldo Conte